www.fgks.org   »   [go: up one dir, main page]

TW200612902A - Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester - Google Patents

Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester

Info

Publication number
TW200612902A
TW200612902A TW094114589A TW94114589A TW200612902A TW 200612902 A TW200612902 A TW 200612902A TW 094114589 A TW094114589 A TW 094114589A TW 94114589 A TW94114589 A TW 94114589A TW 200612902 A TW200612902 A TW 200612902A
Authority
TW
Taiwan
Prior art keywords
cholesterol
lipase
agents
absorption
suppressing
Prior art date
Application number
TW094114589A
Other languages
Chinese (zh)
Inventor
Toshio Hayami
Hideyuki Kishida
Naoki Arai
Shinnichi Yokota
Kazuya Hamada
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of TW200612902A publication Critical patent/TW200612902A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)

Abstract

The present invention has found that human and porcine pancreatic lipase and cholesterol esterase inhibitory activities and the like are possessed by a licorice or licorice extract which has been previously taken orally, or are sufficient in meal experience in the form of a medicine, a chinese herbal remedy, a food additive such as sweetener, or a health food product, or by glabridin, glabrol, glabrene, and 4'-O-methylglabridin contained therein. In addition, it has been proved that giving a feed containing any of these materials to experimental animals suppressed their obesity, and produced the increased excretion of neutral fats and cholesterol into feces, thereby suppressing their absorption in the body. This has enabled the supply of compositions for reducing neutral fats or cholesterol absorption, or for suppressing obesity based on lipase and/or cholesterol inhibition, totally different from dietary fiber-containing compositions which have previously been used commonly.
TW094114589A 2004-05-13 2005-05-05 Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester TW200612902A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004143210 2004-05-13
JP2004271567 2004-09-17

Publications (1)

Publication Number Publication Date
TW200612902A true TW200612902A (en) 2006-05-01

Family

ID=35393981

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094114589A TW200612902A (en) 2004-05-13 2005-05-05 Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester

Country Status (3)

Country Link
JP (1) JPWO2005110400A1 (en)
TW (1) TW200612902A (en)
WO (1) WO2005110400A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689081A (en) * 2016-08-31 2019-04-26 釜山大学校产学协力团 Localised adiposities therapeutic composition and micropin comprising it

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808333A (en) 2006-04-17 2008-02-16 Kaneka Corp Licorice polyphenol preparation
US20080286254A1 (en) 2007-05-17 2008-11-20 Kaneka Corporation Composition comprising licorice polyphenol
US20110123505A1 (en) 2007-08-22 2011-05-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
US20100324075A1 (en) * 2007-12-21 2010-12-23 University Of Cincinnati Therapeutic use of carboxyl ester lipase inhibitors
JP2011231057A (en) * 2010-04-28 2011-11-17 Kao Corp Ceramide production enhancer
JP6236697B2 (en) * 2012-12-27 2017-11-29 株式会社ゆふ・は Absorbing material and soap using the same
JP2018052921A (en) * 2017-08-10 2018-04-05 小林製薬株式会社 Lipid eliminant
JP2019034898A (en) * 2017-08-10 2019-03-07 小林製薬株式会社 Bofu-tsusho-san extract
CN113598253A (en) * 2021-07-14 2021-11-05 云南润攀生物科技有限公司 Ketogenic herbal tea for promoting ketogenic effect and increasing body fat decomposition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000226324A (en) * 1998-11-30 2000-08-15 Kansai Koso Kk Liquid agent composition for cleaning/wiping and for cosmetic water
IL138603A0 (en) * 2000-09-21 2001-10-31 Ready Made 37 1999 Ltd Licorice extract for use as a medicament
TWI329516B (en) * 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
US7524975B2 (en) * 2001-10-11 2009-04-28 Kaneka Corporation Peroxisome proliferator activated receptor ligand and process for producing the same
JP4191420B2 (en) * 2002-03-26 2008-12-03 株式会社カネカ Edible oil and fat composition comprising a licorice hydrophobic extract

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689081A (en) * 2016-08-31 2019-04-26 釜山大学校产学协力团 Localised adiposities therapeutic composition and micropin comprising it
CN109689081B (en) * 2016-08-31 2022-12-16 Sn维亚股份有限公司 Composition for treating local obesity and microneedle comprising same

Also Published As

Publication number Publication date
WO2005110400A1 (en) 2005-11-24
JPWO2005110400A1 (en) 2008-03-21

Similar Documents

Publication Publication Date Title
TW200612902A (en) Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester
MX2009007014A (en) Ground meat and meat analog compositions having improved nutritional properties.
ATE495674T1 (en) FRUIT CHOCOLATE OR SIMILAR
MXPA04009741A (en) Method and dietary composition for improving fat digestibility.
WO2006108582A3 (en) Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
ATE410076T1 (en) FOOD OR ANIMAL FEED CONTAINING BONE HEALTH SUPPORTING PLANT EXTRACT FROM AMELANCHIER
MX2010003651A (en) Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation.
WO2005053710A3 (en) Food composition comprising glucosamine
WO2009010368A3 (en) Composition comprising bacteria and lecithin
TW200740379A (en) Nutrition for obese patients
WO2006069668A8 (en) Method for producing a raw oil from mixtures of micro-organisms and plants, oil produced according to said method and specific uses of the thus produced oil and, optionally, additional refined oil
MX2009006342A (en) Nutritional supplement composition for treatment of ocular diseases.
WO2011033524A3 (en) Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases
MY160409A (en) Compositions for preventing or improving gastrointestinal diseases
UA88165C2 (en) Use of trisubstituted benzopyranones
MX2007004879A (en) Protection of bioactive food ingredients by means of encapsulation.
HK1058459A1 (en) Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and use thereof
CR8265A (en) MILK FRACTIONS AND MILK PREPARATIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES MEDIATED BY COX-2
WO2008102017A3 (en) Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
ATE406169T1 (en) USE OF BANANA EXTRACT TO TREAT INFLAMMATORY BOWL DISEASE
EA201301052A1 (en) BIOLOGICALLY ACTIVE ADDITION TO FOOD FOR NORMALIZATION OF THE LEVEL OF MEN ANDROGENS, GENERAL CONDITION, REDUCTION OF OBESITY
WO2009024991A3 (en) Antiobese compositions containing holopteleλ integrifolia extracts
WO2005051290A8 (en) Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
WO2011019210A3 (en) Dietary supplement, feed and pharmaceutical composition containing chia seed and maca, and preparation method thereof
WO2008022807A3 (en) Lipoxin a4 analogs for the treatment and prevention of intestinal fibrosis